![Cintia Piccina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cintia Piccina
Plus aucun poste en cours
Fortune : 666 $ au 31/05/2026
Profil
Cintia Piccina formerly worked at Adaptimmune Therapeutics Plc, as Chief Commercial Officer from 2022 to 2023, Adaptimmune Therapeutics Plc, as Chief Commercial Officer, AlloVir, Inc., as Chief Commercial Officer from 2023 to 2024, 2seventy Bio, Inc., as SVP-Commercial Oncology & US General Manager from 2021 to 2022, and Novartis Pharmaceuticals Corp., as Vice President-Oncology from 1997 to 2020.
Dr. Piccina received her doctorate degree from the University of Sao Paulo and Masters Business Admin degree from Escola Superior de Propaganda e Marketing.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/04/2025 | 666 438 ( 0,04 % ) | 666 $ | 31/05/2026 |
Anciens postes connus de Cintia Piccina
| Sociétés | Poste | Fin |
|---|---|---|
| ALLOVIRPAR | Corporate Officer/Principal | 01/03/2024 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | 01/02/2022 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/04/2020 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Formation de Cintia Piccina
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Sao Paulo
 University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escola Superior de Propaganda e Marketing
 Escola Superior de Propaganda e Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
